Mattias Mandorfer Selected Research

Mattias Mandorfer Research Topics

Disease

68	Fibrosis (Cirrhosis) 03/2024 - 05/2013
58	Liver Diseases (Liver Disease) 03/2024 - 01/2015
47	Portal Hypertension 03/2024 - 05/2013
21	Hemorrhage 02/2024 - 12/2017
20	Ascites 02/2024 - 01/2014
17	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023 - 01/2013
17	Infections 08/2023 - 01/2013
15	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2017
13	Inflammation (Inflammations) 01/2024 - 01/2018
13	End Stage Liver Disease 06/2023 - 01/2017
10	Hepatitis C 10/2022 - 03/2015
9	Disease Progression 06/2023 - 09/2019
8	Varicose Veins (Varicose Vein) 03/2024 - 01/2018
8	Acute-On-Chronic Liver Failure 01/2024 - 10/2017
8	Thrombosis (Thrombus) 12/2023 - 07/2018
7	Non-alcoholic Fatty Liver Disease 08/2023 - 01/2018
7	Chronic Hepatitis C 01/2021 - 01/2013
6	Hepatic Encephalopathy 02/2024 - 01/2018
5	COVID-19 12/2022 - 01/2021
4	Cholestasis 11/2023 - 02/2015
4	Coinfection 11/2021 - 11/2013
4	Fatty Liver 01/2020 - 01/2018
3	Chronic Hepatitis D 03/2024 - 01/2022
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2024 - 01/2022
3	Hepatitis 01/2024 - 01/2021
3	Sarcopenia 10/2023 - 08/2020
3	Alcoholic Liver Diseases (Alcoholic Liver Disease) 07/2023 - 01/2021
3	Chronic Hepatitis B 01/2023 - 01/2021
3	Anemia 12/2022 - 01/2014
3	HIV Infections (HIV Infection) 01/2016 - 05/2014
2	Thromboembolism 12/2023 - 10/2020
2	Bacterial Infections (Bacterial Infection) 12/2023 - 08/2023
2	Hyperbilirubinemia 11/2023 - 01/2023
2	Hyponatremia 10/2023 - 05/2021
2	Dyslipidemias (Dyslipidemia) 08/2023 - 09/2019
2	Brain Diseases (Brain Disorder) 02/2023 - 05/2021
2	Thrombophilia 01/2023 - 01/2022
2	Liver Failure 12/2022 - 01/2020
2	Liver Neoplasms (Liver Cancer) 04/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

19	4-(3-chlorophenylsulfanyl)piperidineIBA 03/2024 - 02/2015
16	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2014
13	InterferonsIBA 04/2022 - 11/2013
12	von Willebrand FactorIBA 03/2024 - 01/2020
11	Antiviral Agents (Antivirals)IBA 03/2024 - 11/2013
11	C-Reactive ProteinIBA 01/2024 - 01/2018
11	AlbuminsIBA 10/2023 - 01/2018
10	RNA (Ribonucleic Acid)IBA 08/2023 - 01/2013
9	BilirubinIBA 02/2024 - 12/2019
8	SodiumIBA 10/2023 - 09/2015
8	CreatinineIBA 10/2023 - 11/2015
7	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2015
6	Interleukin-6 (Interleukin 6)IBA 08/2023 - 05/2013
6	gadolinium ethoxybenzyl DTPA FDA Link 02/2023 - 01/2017
5	Thrombin FDA Link 02/2024 - 01/2022
5	AntigensIBA 01/2024 - 05/2020
5	Immunoglobulin M (IgM)IBA 05/2023 - 01/2021
5	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 11/2013
4	AmmoniaIBA 10/2023 - 02/2021
4	Immunoglobulin G (IgG)IBA 05/2023 - 05/2013
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2015
3	DiureticsIBA 02/2024 - 01/2018
3	Cytidine Triphosphate (CTP)IBA 10/2023 - 12/2019
3	Immunoglobulin A (IgA)IBA 05/2023 - 05/2013
3	ProcalcitoninIBA 05/2023 - 01/2021
3	Carvedilol (Coreg)FDA LinkGeneric 01/2023 - 01/2017
3	AnticoagulantsIBA 01/2023 - 07/2018
3	TransferasesIBA 01/2023 - 01/2019
3	Propranolol (Inderal)FDA LinkGeneric 01/2023 - 10/2018
3	nasIBA 10/2022 - 01/2021
3	Transaminases (Aminotransferases)IBA 01/2022 - 02/2015
3	ReninIBA 12/2021 - 01/2017
3	LipidsIBA 09/2019 - 01/2017
3	Alanine Transaminase (SGPT)IBA 01/2019 - 01/2015
3	Polytetrafluoroethylene (Teflon)FDA Link 01/2018 - 12/2017
3	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 06/2016 - 05/2014
2	Alkaline PhosphataseIBA 02/2024 - 12/2022
2	Epinephrine (Adrenaline)FDA LinkGeneric 12/2023 - 08/2022
2	Bile Acids and Salts (Bile Acids)IBA 11/2023 - 08/2023
2	EnzymesIBA 09/2023 - 01/2022
2	LipopolysaccharidesIBA 08/2023 - 08/2022
2	bulevirtideIBA 08/2023 - 01/2022
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2023 - 12/2021
2	atezolizumabIBA 01/2023 - 01/2022
2	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2022
2	ThrombomodulinIBA 01/2023 - 01/2022
2	Choline (Choline Chloride)IBA 01/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
2	Complement C3 (C3 Complement)IBA 11/2022 - 01/2014
2	CollagenIBA 11/2022 - 08/2022

Therapy/Procedure

33	Therapeutics 02/2024 - 01/2013
16	Liver Transplantation 10/2023 - 10/2015
13	Transjugular Intrahepatic Portasystemic Shunt 10/2023 - 09/2017
8	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2023 - 12/2017
7	Ligation 11/2023 - 12/2017
4	Contraindications 10/2023 - 05/2014
4	Stents 08/2022 - 12/2017
3	Immunotherapy 10/2023 - 01/2022
3	Art Therapy 08/2023 - 01/2016
2	Duration of Therapy 08/2023 - 11/2013
2	Critical Care (Surgical Intensive Care) 02/2023 - 10/2021